PMN
Price:
$10.35
Market Cap:
$13.53M
ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, tar...[Read more]
Industry
Biotechnology
IPO Date
2007-01-10
Stock Exchange
NASDAQ
Ticker
PMN
According to ProMIS Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.92. This represents a change of 193.33% compared to the average of 3.38 of the last 4 quarters.
The mean historical Current Ratio of ProMIS Neurosciences, Inc. over the last ten years is 3.77. The current 9.92 Current Ratio has changed 26.20% with respect to the historical average. Over the past ten years (40 quarters), PMN's Current Ratio was at its highest in in the December 2021 quarter at 19.07. The Current Ratio was at its lowest in in the June 2023 quarter at 0.17.
Average
3.77
Median
1.33
Minimum
0.52
Maximum
19.07
Discovering the peaks and valleys of ProMIS Neurosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.59%
Maximum Annual Current Ratio = 19.07
Minimum Annual Increase = -94.35%
Minimum Annual Current Ratio = 0.52
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.88 | -89.65% |
| 2024 | 8.52 | 485.23% |
| 2023 | 1.46 | 35.32% |
| 2022 | 1.08 | -94.35% |
| 2021 | 19.07 | 3.59% |
| 2020 | 0.52 | -57.25% |
| 2019 | 1.21 | -24.80% |
| 2018 | 1.61 | -38.85% |
| 2017 | 2.63 | 253.65% |
| 2016 | 0.74 | -61.88% |
The current Current Ratio of ProMIS Neurosciences, Inc. (PMN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.62
5-year avg
6.20
10-year avg
3.77
ProMIS Neurosciences, Inc.’s Current Ratio is less than MapLight Therapeutics, Inc. (22.91), greater than Ernexa Therapeutics Inc. (2.89), greater than OSR Holdings, Inc. (0.16), less than Lipocine Inc. (9.99), greater than Adaptimmune Therapeutics plc (1.52), greater than Edesa Biotech, Inc. (4.76), greater than Adlai Nortye Ltd. (0.65), greater than GeoVax Labs, Inc. (1.06), less than Tharimmune, Inc. (37.75), greater than BioRestorative Therapies, Inc. (2.35),
| Company | Current Ratio | Market cap |
|---|---|---|
| 22.91 | $21.90M | |
| 2.89 | $1.93M | |
| 0.16 | $9.36M | |
| 9.99 | $13.12M | |
| 1.52 | $75.16M | |
| 4.76 | $51.57M | |
| 0.65 | $547.79M | |
| 1.06 | $1.17M | |
| 37.75 | $139.94M | |
| 2.35 | $3.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProMIS Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProMIS Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ProMIS Neurosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for ProMIS Neurosciences, Inc. (PMN)?
What is the highest Current Ratio for ProMIS Neurosciences, Inc. (PMN)?
What is the 3-year average Current Ratio for ProMIS Neurosciences, Inc. (PMN)?
What is the 5-year average Current Ratio for ProMIS Neurosciences, Inc. (PMN)?
How does the current Current Ratio for ProMIS Neurosciences, Inc. (PMN) compare to its historical average?